Skip to main content
. 2022 Nov 11;101(45):e31681. doi: 10.1097/MD.0000000000031681

Table 2.

Clinical outcomes of COVID-19 patients in Si-home (N = 1940).

Early favipiravir treatment (n = 1076) Late favipiravir treatment (n = 864)
Mildly symptomatic and cured at home 1026 (95.4%) 799 (92.5%)
Clinical deterioration 50 (4.6%) 65 (7.5%)
•Cured at home 25 (2.3%) 52 (6.0%)
•Hospital admission 25 (2.3%) 13 (1.5%)
In-hospital death 7 (0.7%) 1 (0.1%)